English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
雲頂新耀發佈2024上半年業績:收入大幅增長158%,首次實現商業化盈利
Aug 29, 2024 00:35 HKT
Yunkang Group's 2024 Interim Revenue Reaches Approximately RMB380 Million
Aug 28, 2024 23:25 HKT
雲康集團2024年中期收益達約人民幣3.80億元
Aug 28, 2024 22:50 HKT
日本厚生劳动省批准了莫德纳公司针对SARS-COV-2 JN.1变异株的COVID-19 mRNA疫苗的部分变更申请
Aug 24, 2024 08:00 HKT
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Aug 24, 2024 08:00 HKT
日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請
Aug 24, 2024 08:00 HKT
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Aug 23, 2024 08:00 HKT
Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)
Aug 22, 2024 14:40 HKT
云顶新耀宣布自主研发的新型mRNA个性化肿瘤治疗性疫苗正式启动临床试验
Aug 22, 2024 14:26 HKT
雲頂新耀宣佈 自主研發的新型mRNA個性化腫瘤治療性疫苗正式啟動臨床試驗
Aug 22, 2024 13:52 HKT
乐普生物公布2024年中期业绩 ADC管线取得重大进展 核心产品营收大增一倍
Aug 22, 2024 11:59 HKT
樂普生物公佈2024年中期業績 ADC管線取得重大進展 核心產品營收大增一倍
Aug 22, 2024 11:35 HKT
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024
Aug 16, 2024 20:47 HKT
业聚医疗2024年上半年纯利达1,880万美元
Aug 16, 2024 20:26 HKT
業聚醫療2024年上半年純利達1,880萬美元
Aug 16, 2024 19:41 HKT
康哲藥業(00867)發佈2024年中期業績:營業額和利潤環比均穩步提升
Aug 16, 2024 16:42 HKT
康哲药业(00867)发布2024年中期业绩:营业额和利润环比均稳步提升
Aug 16, 2024 16:24 HKT
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 13:00 HKT
亚洲公司突破Ac-225制备关键技术
Aug 15, 2024 20:00 HKT
亞洲公司突破Ac-225製備關鍵技術
Aug 15, 2024 20:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: